ESR1 and acute myeloid leukemia: Tamoxifen (Nolvadex) is a nonsteroidal antiestrogen used to treat estrogen-receptor-positive breast cancers, and midostaurin (Rydapt or Tauritmo) is a multitarget kinase inhibitor for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML).